Advertisement
Advertisement
U.S. Markets close in 3 hrs 54 mins
Advertisement
Advertisement
Advertisement
Advertisement

QuidelOrtho Corporation (QDEL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
69.67-2.53 (-3.51%)
As of 12:06PM EDT. Market open.
Advertisement

QuidelOrtho Corporation

9975 Summers Ridge Road
San Diego, CA 92121
United States
858-552-1100
https://www.quidelortho.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees1,600

Key Executives

NameTitlePayExercisedYear Born
Mr. Douglas C. BryantChairman & CEO1.41MN/A1958
Mr. Robert J. Bujarski J.D.Pres & COO770.62kN/A1969
Ms. Michelle A. HodgesGen. Counsel620.61kN/A1960
Dr. Werner Kroll Ph.D.Sr. VP of R&D758.22k2.1M1957
Mr. Joseph M. Busky CPAChief Financial OfficerN/AN/A1968
Ruben ArguetaDirector of Investor RelationsN/AN/AN/A
Mr. Michael S. IskraChief Commercial OfficerN/AN/A1970
Phillip S. AskimVP, Associate Gen. Counsel & Sec.N/AN/AN/A
Dr. Johannes KehlePres of AnDiaTec DivisionN/AN/AN/A
Mr. Rhys de CallierVP of Strategy & Portfolio ManagementN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

QuidelOrtho Corporation provides various in vitro diagnostics products worldwide. The company's product portfolio covers a range of point-of-care tests for infectious diseases, critical cardiac health and autoimmune biomarkers, and clinical and at-home products to detect COVID-19. It provides visually-read lateral flow products in infectious disease and reproductive health; direct fluorescent antibodies in infectious disease and virology; micro-titer production with a focus on bone and complement pathway markets; fluorescent immunoassay products; molecular diagnostic products comprising Savanna, an integrated molecular diagnostic system; immunodiagnostics, clinical chemistry, and integrated testing systems to serve diagnostic labs of all sizes; immunodiagnostic donor screening systems and services that drive blood safety; pre-transfusion testing that automates blood bank workload with software to standardize operations, simplify tasks, and improve productivity; and Ortho Care services and informatics products. The company was founded in 1979 and is headquartered in San Diego, California.

Corporate Governance

QuidelOrtho Corporation’s ISS Governance QualityScore as of July 1, 2022 is 4. The pillar scores are Audit: 8; Board: 3; Shareholder Rights: 3; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement